维普中文期刊产品整合服务
49篇 您的检索式:作者名="Gravis"
    题名 作者 年代 出处 被引量
1Systemic treatment for metastatic prostate cancer显示文摘The management of metastatic prostate cancer(mPCa)has changed over the past ten years.Several new drugs have been approved with significant overall survival benefits in metastatic castration resistant prostate cancer(PCa)including chemotherapy(docetaxel,cabazitaxel),new hormonal therapies(abiraterone,enzalutamide),Radium-223 and immunotherapy.The addition of docetaxel to androgen deprivation therapy(ADT)versus ADT alone in the castration sensitive metastatic setting has gained significant overall survival benefit particularly for high volume disease.More recently two phase III trials have assessed the efficacy of abiraterone plus prednisone plus ADT over ADT alone in newly high risk castrate sensitive mPCa.Determination of the appropriate treatment sequence using these therapies is important for maximizing the clinical benefit in castration sensitive and castration resistant PCa patients.Emerging fields are the identification of new subtypes with molecular characterization and new therapeutic targets.Gwenaelle Gravis 2019Asian Journal of Urology2019,6,2:2
2Cabazitaxel formetastatic castration-resistant prostate cancer progressingafter docetaxel treatment: the TROPIC study in France 显示文摘Pouessel D Oudard S Gravis G 2012Bull Cancer2012,99,78:1
3Calculating the surgically induced refractive change following ocular surgery显示文摘Holladay JT Gravy TV Koch DD 1992J Cataract Refract Surg1992,18,:1
4Myeloid differentiation factor 88-dependent transcriptional regulation of cyclooxygenase-2 expression by CpG DNA:Role of NF-κB and p38显示文摘Yeo SJ Gravis D Yoon JG 2003J Biol Chem2003,14,:1
5(fiyst of two parts)显示文摘Drachman DB Myasthenia gravis 1978N Eng J Med1978,298,3:1
6Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15) a randomised,open-label,phase 3 trial 显示文摘Gravis G Fizazi K Joly F 2013Lancet Oncol2013,14,2:1
7Calculation of the change in coneal astigmatism following cataract extraction显示文摘Gravy TV 1979Ophthalmic Surg1979,10,1:1
8,Madrogen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate can- cer (GETUG-AFU 15):a randomised, open-label, phase 3 trim显示文摘Gravis G Fizazi K Joly F 2013Lancet Oncol2013,14,2:1
9Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy显示文摘Luc George Franck Bladou Valérie Jeanne Bardou Gwenaelle Gravis Agnes Tallet Claude Alzieu Gérard Serment Naji Salem 2004Urology2004,,3:1
10Can the combination of temsirolimus and bevacizumab improve the treatment of metastatic renal cell carcinoma (mR- CC)? Results of the randomized TORAVA phase II trial 显示文摘Escudier B J Negrier S Gravis G 2010J Clin Oncol (Meeting Abstracts)2010,28,15:1
11Stapled hemorrhoidopexy versus milligan-morgan hemorrhoidectomy: a prospective, randomized, multicenter trial with 2-year postoperative follow up 显示文摘Gravie JF Lehur PA Huten N 2005Ann Surg2005,242,1:1
12Plasmid DNA in Streptococcus cremoris Wg2: influence of pH on selection of a variant lacking a protease plasmid显示文摘Otto R de Vos WM Gravieli J 1982Applied and Environmental Microbiology1982,43,6:1
13Stapled hemorrhoidopexy versusMilligan-Morgan Hemorrhoidectomy:a prospective,randomized,multicenter trial with 2-yewr postoper-ative follow up显示文摘Gravie JF Lehur PA Huten N 2005AnnSurg2005,,:1
14Myasthenia gravis: recommendations for clinical research standards 显示文摘Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America 2000Neurology2000,55,1:1
15Stapled hemorrhoidopexy versus Milligan-Morgan hemorrhoideetomy:a prospective,randomized,multicenter trial with 2-year postoperative follow up显示文摘Gravie JF Lehur PA Huten N 2005Ann Surg2005,,:1
16Calculation of the change in coneal astigmatism following cataract extraction显示文摘Gravy TV 1979Ophthalmic Surg1979,10,:1
17A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis, Result of the second interin analysis显示文摘Myasthenla Gravis Clinical Study Group 1993J Neurol Neurosurg Psychiatr1993,56,5:1
18Myeloid differentiation factor 88-dependent transcriptional regulation of cyclooxygenase-2 expression by CpG DNA:Role of NF-KB and p38 显示文摘Yeo SJ Gravis D Yoon JG 2003J Biol Chem2003,278,22:1
19Transient detection of beta-galactosidase activity in hematopoietic cells,following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high -dose chemotherapy显示文摘Bagnis C Chabannon C Gravis G 2002Exp Hematol2002,30,2:1
20Calculation of the change in coneal astigmatism following cataract Extraction 显示文摘Gravy T V 1979Ophthalmic Surg1979,10,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费